{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:38:14Z","timestamp":1787870294931,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long-acting injectable formulations for HIV infection have been approved and are now available in Japan. Although not currently recommended as first-line drugs in Japanese or overseas guidelines, use of such formulations may increase, in accordance with patient conditions and preference. We determine the level of satisfaction with current anti-HIV drugs and analyzed the preferences of patients who favor long-acting injectable drugs based on their satisfaction level with the present anti-HIV drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>People living with HIV (PLWH) who had received antiretroviral therapy (ART) for at least one month and consented to the study between 1 April and 31 December 2021 were included in a survey conducted using a self-administered questionnaire. The content of the survey included satisfaction with seven items (tablet size, ease and feeling when taking the medicine, color, taste, portability, daily oral therapy, and co-payment) related to the anti-HIV drugs they were taking and their need for future drugs (dosage form, frequency of dosing, long-acting injectable, etc.). In addition, factors related to the need for long-acting injectable medications were analyzed with regard to the relationship with satisfaction with anti-HIV drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 667 patients available for analysis were included in this study. Satisfaction with anti-HIV drugs was highest with regard to \u201cco-payment\u201d and lowest with \u201cdaily oral therapy\u201d. Regarding the need for long-acting injectable medications, logistic regression analysis indicated that tablet size and daily oral therapy were significant predictors of patient preference for a once-every-eight-weeks intramuscular formulation in terms of their requirement for long-acting injectable medications (tablet size, OR\u2009=\u20092.14, 95%CI 1.030\u20134.430, p\u2009=\u20090.042; and daily oral therapy, OR\u2009=\u20091.75, 95%CI 1.010\u20133.030, p\u2009=\u20090.044).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients currently receiving anti-HIV drugs who express dissatisfaction with tablet size and daily oral therapy may prefer a long-acting injectable formulation, taking into consideration patient age, employment status, ART history, frequency of daily dosage and concomitant medications other than ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-023-00557-5","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T11:06:03Z","timestamp":1693220763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study"],"prefix":"10.1186","volume":"20","author":[{"given":"Masashi","family":"Ishihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hikasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Tsukiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kunimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Nobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Haruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kashiwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"issue":"1","key":"557_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","volume":"24","author":"HIV-CAUSAL Collaboration","year":"2010","unstructured":"Collaboration HIV-CAUSAL, Ray M, Logan R, Sterne JA, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24(1):123\u201337.","journal-title":"AIDS"},{"issue":"1","key":"557_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/dyv352","volume":"45","author":"C Lesko","year":"2016","unstructured":"Lesko C, Cole S, Hall H, et al. The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009\u201311. Int J Epidemiol. 2016;45(1):140\u201350.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"557_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","volume":"135","author":"E Murphy","year":"2001","unstructured":"Murphy E, Collier A, Kalish L, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135(1):17\u201326.","journal-title":"Ann Intern Med"},{"key":"557_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174360","author":"A Iwamoto","year":"2017","unstructured":"Iwamoto A, Taira R, Yokomaku Y, et al. The HIV care cascade: japanese perspectives. PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0174360.","journal-title":"PLoS ONE"},{"issue":"2","key":"557_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7883\/yoken.JJID.2015.599","volume":"70","author":"N Miyazaki","year":"2017","unstructured":"Miyazaki N, Sugiura W, Gatanaga H, et al. The prevalence of High Antiretroviral Coverage and viral suppression in Japan: an excellent Profile for a downstream human immunodeficiency Virus Care Spectrum. Jpn J Infect Dis. 2017;70(2):158\u201360.","journal-title":"Jpn J Infect Dis"},{"issue":"6","key":"557_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells. Nat Med. 2003;9(6):727\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"557_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","volume":"14","author":"JV Lazarus","year":"2016","unstructured":"Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV\u2014the new quality of life frontier. BMC Med. 2016;14(1):94.","journal-title":"BMC Med"},{"key":"557_CR8","unstructured":"Research group to overcome the challenges of HIV infection and its complications. Guidelines for HIV treatment. March 2022) (in Japanese). 2022. https:\/\/hiv-guidelines.jp\/pdf\/guideline2022.pdf. Accessed 20 Feb 2023."},{"key":"557_CR9","unstructured":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. (DHHS Sep. 21, 2022). https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new-guidelines. Accessed 20 Feb 2023."},{"key":"557_CR10","unstructured":"European AIDS Clinical Society (EACS). Guidelines Version 11.1 October 2022. https:\/\/eacs.sanfordguide.com\/. Accessed 20 Feb 2023."},{"issue":"1","key":"557_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA panel. JAMA. 2023;329(1):63\u201384.","journal-title":"JAMA"},{"key":"557_CR12","unstructured":"Department of Health and Human Services. Aging with HIV Available from: https:\/\/www.hiv.gov\/hiv-basics\/living-well-with-hiv\/taking-care-of-yourself\/aging-with-hiv. Accessed 20 Feb 2023."},{"key":"557_CR13","unstructured":"National Institute on Aging. HIV, AIDS, and Older Adults Available from: https:\/\/www.nia.nih.gov\/health\/hiv-aids-and-older-adults. Accessed 20 Feb 2023."},{"key":"557_CR14","unstructured":"The well project, Aging. and HIV Available from: https:\/\/www.thewellproject.org\/hiv-information\/aging-and-hiv. Accessed 20 Feb 2023."},{"issue":"1","key":"557_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-020-00268-1","volume":"17","author":"J Cohen","year":"2020","unstructured":"Cohen J, Beaubrun A, Bashyal R, Huang A, Li J, Baser O. Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries. AIDS Res Ther. 2020;17(1):1\u201312.","journal-title":"AIDS Res Ther"},{"issue":"5","key":"557_CR16","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10461-021-03515-2","volume":"26","author":"I Koga","year":"2022","unstructured":"Koga I, Wakatabe R, Okamoto N, Sasai A, Kambara K, Maldonado A, de Los Rios P, Okoli C. Factors Associated with treatment satisfaction among people living with HIV in Japan and other selected countries: examination of the intertwined roles of medication, patient, and provider characteristics. AIDS Behav. 2022;26(5):1633\u201351.","journal-title":"AIDS Behav"},{"issue":"3","key":"557_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10461-020-03055-1","volume":"25","author":"delos Patricia","year":"2021","unstructured":"Patricia delos, Rios C, Okoli E, Castellanos B, Allan B, Young G, Brough M, Muchenje A, Eremin GM, Corbelli M, McBritton WD, Hardy. Nicolas Van de Velde. Physical, emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and their impact on indicators of quality of life: findings from the positive perspectives study. AIDS Behav. 2021;25(3):961\u201372.","journal-title":"AIDS Behav"},{"issue":"5","key":"557_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s10461-020-02973-4","volume":"25","author":"C Okoli","year":"2021","unstructured":"Okoli C, Brough G, Allan B, et al. Shared decision making between patients and Healthcare Providers and its Association with Favorable Health Outcomes among people living with HIV. AIDS Behav. 2021;25(5):1384\u201395.","journal-title":"AIDS Behav"},{"issue":"3","key":"557_CR19","first-page":"181","volume":"86","author":"V Tzaneva","year":"2013","unstructured":"Tzaneva V, Iacob T. A better communication with the patients improves the management of HIV disease: a nonsystematic review. Clujul Med. 2013;86(3):181\u20134.","journal-title":"Clujul Med"},{"issue":"2","key":"557_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jiac.2018.10.006","volume":"25","author":"DJ Ruzicka","year":"2019","unstructured":"Ruzicka DJ, Imai K, Takahashi K, Naito T. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: a hospital claims database study. J Infect Chemother. 2019;25(2):89\u201395.","journal-title":"J Infect Chemother"},{"issue":"3","key":"557_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.25100\/cm.v50i3.4128","volume":"50","author":"S Fern\u00e1ndez Ca\u00f1abate","year":"2019","unstructured":"Fern\u00e1ndez Ca\u00f1abate S, Ortega Val\u00edn L. Polypharmacy among HIV infected people aged 50 years or older. Colomb Med (Cali). 2019;50(3):142\u201352.","journal-title":"Colomb Med (Cali)"},{"key":"557_CR22","first-page":"749","volume":"8","author":"LJ Gleason","year":"2013","unstructured":"Gleason LJ, Luque AE, Shah K. Polypharmacy in the HIV-infected older adult population. Clin Interv Aging. 2013;8:749\u201363.","journal-title":"Clin Interv Aging"},{"issue":"Suppl 1","key":"557_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00002030-200418001-00004","volume":"18","author":"CH Hinkin","year":"2004","unstructured":"Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):19\u201325.","journal-title":"AIDS"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00557-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:40:06Z","timestamp":1700268006000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00557-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00557-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2791324\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"7 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in line with the principles of the Declaration of Helsinki. We obtained approved by the institutional review board of Gifu University Hospital (ethical approval with Number 2021-027), and of all the other study sites. In addition, permission from facilities was acquired to use anonymized data. The purpose and significance of the study were explained to the participants, while written informed consent was obtained from the participants who could consent. The parents gave consent for those under 18 years while they gave their assent to participate. Furthermore, the confidentiality of the collected data was ensured by the use of code numbers rather than personal identification and the locking of the checklist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}